Web Images Videos Maps News Shopping Gmail more »
Sign in
Scholar Home  
  Advanced Scholar Search
Scholar Preferences
Scholar Results 1 - 5 of 5 citing Nagamatsu: Imaging Docking and Fusion of Insulin Granules Induced by Antidiabetes Agents. (0.07 sec) 

The ins and outs of secretion from pancreatic beta-cells: control of single-vesicle …


PE MacDonald, P Rorsman - Physiology (Bethesda, Md.), 2007 - ncbi.nlm.nih.gov
Exocytosis of insulin-containing secretory vesicles in pancreatic beta-cells is crucial to maintenance
of plasma glucose levels. They fuse with the plasma membrane in a regulated manner to release
their contents and are subsequently recaptured either intact or through conventional ...
Cited by 13 - Related articles - BL Direct - All 4 versions

Tissue plasminogen activator (t-PA) promotes neutrophil degranulation and MMP-9 …

- highwire.org
E Cuadrado, L Ortega, M Hernandez- … - Journal of Leukocyte …, 2008 - jleuk.highwire.org
Recombinant tissue plasminogen activator (t-PA), the only approved stroke treatment, is used
for clot lysis within the occluded brain artery. Unfortunately, matrix metalloproteinase-9
(MMP-9) concentration increases after t-PA treatment and has been related to ...
Cited by 6 - Related articles - All 6 versions

Insulin exocytosis in Goto-Kakizaki rat beta-cells subjected to long-term glinide or …


J Kawai, M Ohara-Imaizumi, Y Nakamichi, T Okamura, … - Biochem. J, 2008 - biochemj.org
Sulfonylurea and glinide drugs display different effects on insulin granule motion in single
β-cells in vitro. We therefore investigated the different effects that these drugs manifest towards
insulin release in an in vivo long-term treatment model. Diabetic GK (Goto-Kakizaki) rats ...
Cited by 4 - Related articles - Cached - BL Direct - All 5 versions

Mitiglinide: a rapid-and short-acting non-sulfonylurea insulinotropic agent for the …


WJ Malaisse - Expert Opin. Pharmacother., 2008 - informahealthcare.com
In 1994, four articles [1-4] were published concerning a novel rapid- and short-acting non-sulfonylurea
hypoglycemic agent, ie, compound KAD-1229 developed at Kissei Pharmaceutical Co. Ltd
(Japan). It was later proposed [5] that this compound belongs to a family of ...
Cited by 1 - Related articles - All 7 versions

[PDF] Glinide, but not sulfonylurea, can evoke insulin exocytosis by repetitive stimulation; …


K Aoyagi, M Ohara-Imaizumi, C Nishiwaki, Y … - hindawi.com
Page 1. Glinide, but not sulfonylurea, can evoke insulin exocytosis by repetitive stimulation;
Imaging analysis of insulin exocytosis by secretagogue-induced repetitive stimulations Kyota
Aoyagi, Mica Ohara-Imaizumi, Chiyono Nishiwaki, Yoko Nakamichi, and Shinya Nagamatsu ...
View as HTML


 


Go to Google Home - About Google - About Google Scholar

©2009 Google